Cigna Corporation (NYSE:CI) Insider Matthew G. Manders Sells 24,357 Shares

Cigna Corporation (NYSE:CI) insider Matthew G. Manders sold 24,357 shares of the stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $175.01, for a total transaction of $4,262,718.57. Following the sale, the insider now owns 46,256 shares in the company, valued at $8,095,262.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Cigna Corporation (NYSE CI) opened at 177.03 on Friday. The firm’s 50-day moving average is $173.66 and its 200 day moving average is $160.28. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $181.00. The company has a market cap of $44.57 billion, a price-to-earnings ratio of 20.43 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last issued its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the prior year, the business earned $1.98 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. On average, equities analysts expect that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cigna Corporation (NYSE:CI) Insider Matthew G. Manders Sells 24,357 Shares” was posted by BNB Daily and is owned by of BNB Daily. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/cigna-corporation-nyseci-insider-sells-4262718-57-in-stock-updated-updated-updated.html.

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Cigna Corporation by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after buying an additional 424,469 shares during the last quarter. BlackRock Inc. boosted its position in shares of Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares during the last quarter. State Street Corp boosted its position in shares of Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock worth $1,631,451,000 after buying an additional 190,323 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares during the last quarter. Finally, FMR LLC boosted its position in shares of Cigna Corporation by 6.7% in the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after buying an additional 432,978 shares during the last quarter. 87.61% of the stock is owned by institutional investors.

CI has been the topic of a number of analyst reports. Jefferies Group LLC reiterated a “buy” rating and set a $178.00 price objective (up from $172.00) on shares of Cigna Corporation in a research note on Sunday, April 23rd. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a research note on Tuesday, April 25th. Stifel Nicolaus raised their price target on shares of Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, May 5th. Royal Bank Of Canada raised their price target on shares of Cigna Corporation from $172.00 to $177.00 and gave the company an “outperform” rating in a research note on Monday, May 8th. Finally, Deutsche Bank AG raised their price target on shares of Cigna Corporation from $172.00 to $175.00 and gave the company a “buy” rating in a research note on Wednesday, May 10th. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Cigna Corporation currently has a consensus rating of “Buy” and a consensus price target of $180.44.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply